-
-
-
-
-
-
-
FDA recommends second phase 3 trial for Reviva's schizophrenia drug
-
-
-
-
-
-
-
Chardan Capital Markets Starts Reviva Pharmaceuticals (RVPH) at Buy, PT $2
-
-
-
-
-
-
-
Benchmark Reiterates Speculative Buy Rating on Reviva Pharmaceuticals (RVPH)
-
-
-
-
-
-
-
Applied Therapeutics Inc. (APLT) Appoints John H. Johnson as Executive Chairman
-
-
-
-
-
-
-
Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q2 EPS by 4c
-
-
-
-
416,807 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

